Promising disease-modifying therapies for Parkinson's disease
Promising disease-modifying therapies for Parkinson’s disease | Science Translational
Medicine news careers commentary Journals Science Science brought to you byGoogle Indexer …
Medicine news careers commentary Journals Science Science brought to you byGoogle Indexer …
Emerging therapies for Parkinson's disease
W Poewe, P Mahlknecht, J Jankovic - Current opinion in …, 2012 - journals.lww.com
Emerging therapies for Parkinson's disease : Current Opinion in Neurology Emerging
therapies for Parkinson's disease : Current Opinion in Neurology Log in or Register Subscribe …
therapies for Parkinson's disease : Current Opinion in Neurology Log in or Register Subscribe …
Emerging therapies in Parkinson disease—repurposed drugs and new approaches
Parkinson disease (PD) treatment options have conventionally focused on dopamine
replacement and provision of symptomatic relief. Current treatments cause undesirable …
replacement and provision of symptomatic relief. Current treatments cause undesirable …
Future treatments for Parkinson's disease: surfing the PD pipeline
RA Hauser - International Journal of Neuroscience, 2011 - Taylor & Francis
Our current wish list for the treatment of Parkinson's disease (PD) includes therapies that will
provide robust and sustained antiparkinsonian benefit through the day, ameliorate or …
provide robust and sustained antiparkinsonian benefit through the day, ameliorate or …
Drugs used to treat Parkinson's disease, present status and future directions
OME Abdel-Salam - … (Formerly Current Drug Targets-CNS & …, 2008 - ingentaconnect.com
Parkinson's disease (PD) is the second most common neurodegenerative disorder, after
Alzheimer's disease. In PD'motor symptoms result from the degeneration and loss of …
Alzheimer's disease. In PD'motor symptoms result from the degeneration and loss of …
Rationale for current therapies in Parkinson's disease
J Romrell, HH Fernandez, MS Okun - Expert opinion on …, 2003 - Taylor & Francis
Parkinson's disease (PD) is a neurodegenerative disorder that affects an estimated 1 million
people in the US and tens of millions worldwide. Medication therapy has made significant …
people in the US and tens of millions worldwide. Medication therapy has made significant …
[HTML][HTML] Novel Therapies for Parkinsonian Syndromes–Recent Progress and Future Perspectives
D Przewodowska, W Marzec… - Frontiers in Molecular …, 2021 - frontiersin.org
Background: Atypical parkinsonian syndromes are rare, fatal neurodegenerative diseases
associated with abnormal protein accumulation in the brain. Examples of these syndromes …
associated with abnormal protein accumulation in the brain. Examples of these syndromes …
[HTML][HTML] Therapy for Parkinson's disease: what is in the pipeline?
F Stocchi - Neurotherapeutics, 2014 - Elsevier
Despite advances in the treatment of Parkinson's disease there are still many unmet needs,
including neuroprotection, treatment of motor complications, treatment of dyskinesia …
including neuroprotection, treatment of motor complications, treatment of dyskinesia …
Therapeutic innovation in Parkinson's disease: a 2020 update on disease-modifying approaches
D Colombo, P Pnevmatikou, E Melloni… - Expert Review of …, 2020 - Taylor & Francis
Introduction Parkinson's disease (PD) is the second most common neurodegenerative
disorder affecting more than 10 million patients worldwide. Despite increasing …
disorder affecting more than 10 million patients worldwide. Despite increasing …
[HTML][HTML] Parkinson's disease drug therapies in the clinical trial pipeline: 2020
K McFarthing, S Buff, G Rafaloff… - Journal of …, 2020 - content.iospress.com
Background: The majority of current pharmacological treatments for Parkinson's disease
(PD) were approved for clinical use in the second half of the last century and they only …
(PD) were approved for clinical use in the second half of the last century and they only …